Mitotane is a medication used to treat certain types of tumors that grow in the adrenal glands. It works by stopping the adrenal glands from making hormones. It's sometimes called Chloditan.
Every report comes from a Lived member, sent anonymously.
Have you tried Mitotane for Adrenal Cortical Carcinoma?
Mitotane, sold in the US as Lysodren, is an oral cancer medicine used to treat adrenocortical carcinoma (ACC), a rare cancer that starts in the outer layer of the adrenal glands, the small glands above the kidneys that make cortisol and other steroid hormones. It is FDA approved for ACC that cannot be removed with surgery, whether or not the tumor is producing excess hormones. Specialists also use it in other ACC situations. After a tumor has been completely removed, European expert guidelines suggest mitotane for people at high risk of the cancer coming back, such as when the tumor was advanced or fast growing. For lower-risk tumors, a 2023 randomized trial found no clear benefit, so that decision is more individual. In advanced disease, mitotane may be used alone or together with chemotherapy. Because ACC is rare, treatment is ideally planned by a team experienced with this cancer.
Mitotane is chemically related to an old insecticide and is toxic to cells of the adrenal cortex, the hormone-making layer of the adrenal gland. It damages those cells and lowers their steroid production, which can slow or shrink adrenal cancer and reduce symptoms in tumors that make excess hormones. It also changes how the body breaks down steroid hormones. Exactly how it acts is still not fully understood. The same action affects healthy adrenal tissue, which is why most people taking mitotane need replacement steroid hormones.
Mitotane comes as tablets taken by mouth, usually three or four times a day with food. It is better absorbed with a meal or snack that contains some fat, and keeping the timing consistent with meals helps keep levels steady. Swallow the tablets whole; do not crush, chew or split them. Caregivers who handle the tablets should wear disposable gloves, because mitotane is considered a hazardous drug. The dose starts at a set range and is raised gradually based on side effects and regular blood tests of the mitotane level. The usual target is a blood level of 14 to 20 mg/L (milligrams per liter). Below that range the drug may be less effective, and above 20 mg/L nervous system side effects become more likely. Reaching the target often takes 3 to 5 months. Mitotane builds up in body fat, so levels can rise unexpectedly even on a steady dose and stay detectable for weeks to months after stopping. Because mitotane suppresses the adrenal glands, most people also take a daily steroid such as hydrocortisone to replace cortisol, and sometimes a second hormone such as fludrocortisone. Mitotane speeds up steroid breakdown, so replacement doses are often higher than usual. If a dose is missed or vomited, take the next dose at the usual time rather than doubling up.
Side effects are very common. Loss of appetite, nausea, vomiting, diarrhea and stomach discomfort are frequent, along with tiredness, dizziness, unsteadiness and rash. Mitotane can also raise cholesterol and triglycerides, cause an underactive thyroid, and lower testosterone in men, sometimes with breast enlargement. Many of these are managed by adjusting the dose or adding treatment. Nervous system effects such as drowsiness, sluggishness, vertigo, confusion or trouble concentrating are more likely at higher blood levels. Report new or worsening symptoms, and do not drive or operate dangerous machinery while they are present. Contact the care team right away for yellowing of the skin or eyes or dark urine (possible liver injury); fever, other signs of infection, unusual bruising or bleeding, or unusual paleness (possible low blood counts); or, for women who still have periods, pelvic pain or unexpected vaginal bleeding, since mitotane can cause large ovarian cysts.
Mitotane carries an FDA boxed warning about adrenal crisis, a dangerous shortage of cortisol. Because mitotane suppresses the adrenal glands, the body cannot raise cortisol during physical stress. If you develop a serious infection or fever, have a significant injury or go into shock, stop mitotane and contact the care team immediately, because extra steroids are needed. Severe weakness, confusion, fainting or severe vomiting can mean adrenal crisis is happening; call 911. Ask the care team for a sick-day plan in advance. Mitotane strongly speeds up the liver's breakdown of many other medicines, which can make them less effective. The label advises avoiding warfarin (a blood thinner), hormonal birth control and other medicines that depend on precise levels, and avoiding spironolactone (a diuretic and hormone blocker), which can block mitotane's effect. Review every medicine and supplement with the oncologist or pharmacist before starting. Mitotane can cause bleeding problems by affecting platelet function. Tell surgeons and dentists that you take it; it is usually paused before planned surgery, and a special platelet test may be needed before surgery or dental work. Mitotane can harm a developing baby. People who could become pregnant should use effective nonhormonal birth control during treatment and for as long as mitotane is detectable in the blood after stopping. Breastfeeding is not recommended during that time.
Mitotane is a long-term treatment that requires close follow-up. Expect blood tests about every 2 weeks at first and after dose changes, checking mitotane levels, liver function, blood counts and hormones, and then roughly monthly once stable. Premenopausal women also have periodic pelvic ultrasounds. Thyroid and cholesterol levels are checked, and hormone test results can be harder to interpret because mitotane raises the proteins that carry hormones in the blood. Side effects often make the first months the hardest, and dose adjustments are common. Benefit is judged with scans over time, and responses vary widely: some tumors shrink or stop growing, others do not. After surgery, the length of treatment is set by the specialist team (the main recent trial used two years), while in advanced disease it continues as long as it helps and is tolerated. Because the drug lingers in body fat, levels and hormone replacement still need monitoring after stopping.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Mitotane, what you've noticed, or ask the community a question.